CERN’s ALPHA collaboration has reported the first measurement of the antihydrogen spectrum. [ + ]

Researchers at Monash University have used X-ray beams created by the Australian Synchrotron (AS) to discover how enzymes work to dissolve blood clots and clean up damaged tissue in the body - a finding that could ultimately lead to a reduction in the number of heart disease-related deaths occurring each year as a result of blood clots. [ + ]

Osprey Medical, a US-headquartered medical device company developing products based on Australian research, plans to list on the ASX via a $20m IPO. [ + ]

AusBiotech is pleased to announce that the first edition for 2012 (March issue) of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a special medical technology edition. [ + ]

The Carnegie Innovation Fund has committed to invest up to $5 million in NSW-based prostate cancer diagnostic company Minomic International. [ + ]

Bionomics (ASX:BNO) shares grew 12.4% in two days after Standard & Poor's added the company to the S&P All Ordinaries index during its latest rebalance. [ + ]

Portions of the gorilla genome are closer to humans than we are to chimpanzees, shedding light on the evolution of our species. [ + ]

A Murdoch University researcher has helped rewrite history after radiocarbon dating and genetic analysis proved that Scandinavian conifers in the high arctic survived the last ice age for several thousands of years. Until now, it was presumed that the Scandinavian landscape was devoid of trees during the ice age. [ + ]

University of Wollongong scientists are behind the establishment of a global consortium which is using sunlight to convert water into important chemical fuels such as hydrogen gas. The research promises a significant reduction of greenhouse gas emissions by reducing CO₂ from fossil fuel use. [ + ]

Lonza has launched its new global company website which will provide users with the company's complete life science market representation. [ + ]

Roche now offers an updated portfolio for the early detection of hepatitis C virus (HCV) infection and personalised disease management. Its improved diagnostics and patient monitoring tools allow for HCV testing with high performance in early infection and ease of use, allowing clinicians to work efficiently and to suit individual patient treatment. [ + ]

A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer. The study builds on previous research which found that women using oral contraception have a temporarily increased risk of breast cancer and cervical cancer and a decreased risk of ovarian cancer and cancer of the lining of the womb. [ + ]

United Bioresearch has been appointed Australian distributor for the full range of ACTGene products. [ + ]

AusBiotech has announced the final chance for biotech business development professionals to attend the annual dedicated Business Development Forum and Workshop (BD Forum) in Queensland. [ + ]

Japan's Nippon Zoki Pharmaceutical has agreed to assess Phosphagenics' (ASX:POH) TPM/diclofenac pain patch for its suitability in the Japan and US markets. [ + ]